1. Home
  2. PRAX vs SM Comparison

PRAX vs SM Comparison

Compare PRAX & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$259.15

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo SM Energy Company

SM

SM Energy Company

HOLD

Current Price

$38.94

Market Cap

9.1B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SM
Founded
2015
1908
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PRAX
SM
Price
$259.15
$38.94
Analyst Decision
Strong Buy
Buy
Analyst Count
21
18
Target Price
★ $650.00
$44.56
AVG Volume (30 Days)
498.9K
★ 2.7M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
★ 2.23%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 3.34
Revenue
N/A
★ $3,154,000,000.00
Revenue This Year
N/A
$156.40
Revenue Next Year
$39,256.17
$0.95
P/E Ratio
★ N/A
$11.83
Revenue Growth
N/A
★ 17.24
52 Week Low
$154.46
$17.45
52 Week High
$392.70
$41.56

Technical Indicators

Market Signals
Indicator
PRAX
SM
Relative Strength Index (RSI) 38.80 62.07
Support Level $238.77 $27.39
Resistance Level $356.02 $41.56
Average True Range (ATR) 12.63 1.11
MACD -0.52 0.40
Stochastic Oscillator 35.55 88.13

Price Performance

Historical Comparison
PRAX
SM

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

Share on Social Networks: